Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBE022 add-on to atosiban for threatened spontaneous preterm labour (phase 2a)
2017-002579-25Phase 2Completed
- Sponsor
- ObsEva SA
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Preterm labor (PTL) comparing OBE022 + atosiban with Placebo + atosiban (2 arms). Primary endpoint: Proof-of-concept efficacy and safety of OBE022 added to atosiban. Started Aug 2017; status: completed.
02
Drugs
ebopiprant
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on 2017-002579-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002579-25.